Skip to main content

Table 2 Between-group comparisons of baseline demographics, APOE-ε4 carrier status in the longitudinal subsample

From: Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease

 

ATN groups (n)

Statistical tests p (p.adj)

 

Stable CN

A−/T−/N− (77)

Stable

A+/T−/N− (18)

Stable

A+/T+ or N+ (89)

Stable

A−/T+ or N+ (29)

F/χ2/η2 (p)

A−/T−/N− vs. A+/T−/N−

A−/T−/N− vs. A+/T+ or N+

A−/T−/N− vs. A−/T+ or N+

A+/T+/N+ vs. A−/T+ or N+

Age mean (SD)

60.04 (8.83)

66.17 (8.34)

68.70 (6.78)

66.52 (9.10)

F = 16.56, η2 = 0.15 (< 0.001)

a< 0.01 (< 0.05)

a< .001 (< 0.001)

a< .001 (< 0.001)

an.s (n.s.)

Female n (%)

42 (54.54)

14 (77.78)

43 (48.31)

14 (48.28)

χ2 = 5.55, (0.135)

b

b

b

b

APOE-ε4+ n (%) [missing n]

28 (36.36) [n = 0]

13 (72.22) [n = 0]

66 (74.16) [n = 1]

10 (34.48) [n = 0]

χ2 = 32.14, (< 0.001)

b

b

b

b

Recruited as controls n (%)

25 (32.47)

1 (5.56)

10 (11.24)

4 (13.79)

 

b

b

b

b

SCD n (%)

52 (67.53)

7 (38.89)

23 (25.84)

13 (44.83)

 

b

b

b

b

MCI

n (%)

0 (0)

10 (55.55)

56 (62.92)

12 (41.38)

 

b

b

b

b

*CN n (%)/*MCI n (%)

77 (100)/0 (0)

7 (38.89)/11 (61.11)

28 (31.46)/61 (68.54)

17 (58.62)/12 (41.38)

**χ2 = 8.90, (< 0.01)

b

b

b

b

  1. Significant statistical tests (ANOVA or ANCOVA, or between group comparisons after correction for multiple testing) are indicated in bold
  2. A±, CSF positive or negative for amyloid plaques; T±, CSF positive or negative for tau-tangles; N±, CSF positive or negative marker for neurodegeneration; SD, standard deviation; n, number of cases; %, percentage; F, F statistic; χ2, chi square statistic; η2, eta-squared; vs., versus; SCD, Subjective Cognitive Decline; CN, Cognitively Normal; MCI, Mild Cognitive Impairment
  3. *Tally of CN and MCI according to our cognitive screening battery, regardless of recruitment as control or SCD status
  4. **Chi-square analyses do not include the CN A−/T−/N/− group
  5. aANOVA post-hoc (Bonferroni–Holm)
  6. bNo post-hoc comparisons performed